Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-9-16
pubmed:abstractText
Adiponectin, an adipocytokine secreted by fat tissue, may prevent development of diabetes type II, as high adiponectin levels are linked with insulin sensitivity. In contrast, tumour necrosis factor (TNF)-alpha, which is also produced by fat tissue, leads to insulin resistance and furthermore inhibits adiponectin mRNA production and secretion of the protein. However, adiponectin also negatively regulates TNF-alpha levels. Therefore, we set out to test whether an infusion of endotoxin would influence circulating adiponectin levels in healthy human subjects. Twenty-three healthy human subjects were injected with endotoxin (2 ng/kg body weight); eight of these subjects were also injected with saline and served as controls. Plasma levels of adiponectin, TNF-alpha and interleukin-6 were measured at 0, 1.5, 2, 4, 8 and 24 h. TNF-alpha and interleukin-6 levels peaked at 1.5 h and 2 h, respectively. Control subjects injected with saline showed a decrease in adiponectin plasma levels with time (P < 0.05) presumably owing to the effect of fasting or physical inactivity. However, there was no change in adiponectin plasma levels in endotoxin injected subjects, thus the effect of fasting was opposed. In conclusion, circulating adiponectin levels are reduced during a resting and fasting state, an effect reversed by endotoxin injection.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-10604883, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-10845877, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-10961870, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-10982546, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-11061537, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-11172066, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-11238217, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-11246823, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-11479627, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-12068289, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-12351435, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-12368665, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-2124934, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-6354950, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-7678183, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-7738205, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-7850934, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-8609227, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-8631877, http://linkedlifedata.com/resource/pubmed/commentcorrection/12974762-9512423
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
107-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Circulating adiponectin levels during human endotoxaemia.
pubmed:affiliation
Department of Infectious Diseases, University Hospital Rigshospitalet, Copenhagen, Denmark. pernille_keller@yahoo.dk
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't